Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Culig

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|May 2, 1997
Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell linesM Widschwendter, G Daxenbichler, Z Culig, et al.
Cancer Research|January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell linesT Putz, Z Culig, I E Eder, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6Hannes Steiner, Andreas P Berger, S Godoy-Tundidor, et al.
The Prostate|June 1, 1996
Regulation of prostatic growth and function by peptide growth factorsZ Culig, A Hobisch, M V Cronauer, et al.
The Journal of Pathology|July 1, 1997
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptorsA Hobisch, A Hittmair, G Daxenbichler, et al.
Cancer Gene Therapy|August 5, 2000
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneZ Culig, A Hobisch, M V Cronauer, et al.
Journal of Cellular Biochemistry|December 16, 2006
Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaPS Koochekpour, T-J Lee, R Wang, et al.
Cancer Detection and Prevention|January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosteroneZ Culig, J Stober, A Gast, et al.
European Urology|May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trialsH Klocker, Z Culig, I E Eder, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|May 2, 1997
Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell linesM Widschwendter, G Daxenbichler, Z Culig, et al.
Cancer Research|January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell linesT Putz, Z Culig, I E Eder, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6Hannes Steiner, Andreas P Berger, S Godoy-Tundidor, et al.
The Prostate|June 1, 1996
Regulation of prostatic growth and function by peptide growth factorsZ Culig, A Hobisch, M V Cronauer, et al.
The Journal of Pathology|July 1, 1997
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptorsA Hobisch, A Hittmair, G Daxenbichler, et al.
Cancer Gene Therapy|August 5, 2000
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneZ Culig, A Hobisch, M V Cronauer, et al.
Journal of Cellular Biochemistry|December 16, 2006
Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaPS Koochekpour, T-J Lee, R Wang, et al.
Cancer Detection and Prevention|January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosteroneZ Culig, J Stober, A Gast, et al.
European Urology|May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trialsH Klocker, Z Culig, I E Eder, et al.
Pageof 6